266 related articles for article (PubMed ID: 23988779)
1. Potentiation of 5-fluorouracil encapsulated in zeolites as drug delivery systems for in vitro models of colorectal carcinoma.
Vilaça N; Amorim R; Machado AF; Parpot P; Pereira MF; Sardo M; Rocha J; Fonseca AM; Neves IC; Baltazar F
Colloids Surf B Biointerfaces; 2013 Dec; 112():237-44. PubMed ID: 23988779
[TBL] [Abstract][Full Text] [Related]
2. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study.
Puri R; Jain S
Anticancer Drugs; 2012 Oct; 23(9):923-34. PubMed ID: 22926258
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.
Zhang C; Li G; Wang Y; Cui F; Zhang J; Huang Q
Int J Pharm; 2012 Oct; 436(1-2):272-81. PubMed ID: 22721846
[TBL] [Abstract][Full Text] [Related]
4. Nanoporous multilayer poly(L-glutamic acid)/chitosan microcapsules for drug delivery.
Yan S; Rao S; Zhu J; Wang Z; Zhang Y; Duan Y; Chen X; Yin J
Int J Pharm; 2012 May; 427(2):443-51. PubMed ID: 22301425
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro evaluation of 5-flourouracil loaded magnetite-zeolite nanocomposite (5-FU-MZNC) for cancer drug delivery applications.
Sağir T; Huysal M; Durmus Z; Kurt BZ; Senel M; Isık S
Biomed Pharmacother; 2016 Feb; 77():182-90. PubMed ID: 26796283
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
Rajan M; Raj V; Al-Arfaj AA; Murugan AM
Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
[TBL] [Abstract][Full Text] [Related]
7. Assam Bora rice starch based biocompatible mucoadhesive microsphere for targeted delivery of 5-fluorouracil in colorectal cancer.
Ahmad MZ; Akhter S; Anwar M; Ahmad FJ
Mol Pharm; 2012 Nov; 9(11):2986-94. PubMed ID: 22994847
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
[TBL] [Abstract][Full Text] [Related]
9. Surface functionalization of zeolite-based drug delivery systems enhances their antitumoral activity in vivo.
Vilaça N; Bertão AR; Prasetyanto EA; Granja S; Costa M; Fernandes R; Figueiredo F; Fonseca AM; De Cola L; Baltazar F; Neves IC
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():111721. PubMed ID: 33545872
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis.
Alvi IA; Madan J; Kaushik D; Sardana S; Pandey RS; Ali A
Anticancer Drugs; 2011 Sep; 22(8):774-82. PubMed ID: 21799471
[TBL] [Abstract][Full Text] [Related]
11. The Potential Anticancer Activity of 5-Fluorouracil Loaded in Cellulose Fibers Isolated from Rice Straw.
Yusefi M; Shameli K; Jahangirian H; Teow SY; Umakoshi H; Saleh B; Rafiee-Moghaddam R; Webster TJ
Int J Nanomedicine; 2020; 15():5417-5432. PubMed ID: 32801697
[TBL] [Abstract][Full Text] [Related]
12. Poly(3-hydroxybutyrate-CO-3-hydroxyvalerate) PHBHV biocompatible nanocarriers for 5-FU delivery targeting colorectal cancer.
Radu IC; Hudita A; Zaharia C; Galateanu B; Iovu H; Tanasa EV; Georgiana Nitu S; Ginghina O; Negrei C; Tsatsakis A; Velonia K; Shtilman M; Costache M
Drug Deliv; 2019 Dec; 26(1):318-327. PubMed ID: 30896267
[TBL] [Abstract][Full Text] [Related]
13. Polymeric nanoparticles for oral delivery of 5-fluorouracil: Formulation optimization, cytotoxicity assay and pre-clinical pharmacokinetics study.
Mattos AC; Altmeyer C; Tominaga TT; Khalil NM; Mainardes RM
Eur J Pharm Sci; 2016 Mar; 84():83-91. PubMed ID: 26775869
[TBL] [Abstract][Full Text] [Related]
14. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
15. Research on 5-fluorouracil as a drug carrier materials with its in vitro release properties on organic modified magadiite.
Ge M; Tang W; Du M; Liang G; Hu G; Jahangir Alam SM
Eur J Pharm Sci; 2019 Mar; 130():44-53. PubMed ID: 30660800
[TBL] [Abstract][Full Text] [Related]
16. Controlled release of 5-fluorouracil from microporous zeolites.
Spanakis M; Bouropoulos N; Theodoropoulos D; Sygellou L; Ewart S; Moschovi AM; Siokou A; Niopas I; Kachrimanis K; Nikolakis V; Cox PA; Vizirianakis IS; Fatouros DG
Nanomedicine; 2014 Jan; 10(1):197-205. PubMed ID: 23916887
[TBL] [Abstract][Full Text] [Related]
17. Formulation, in vitro drug release study and anticancer activity of 5-fluorouracil loaded gellan gum microbeads.
Sahoo SK; Sahoo SK; Behera A; Patil SV; Panda SK
Acta Pol Pharm; 2013; 70(1):123-7. PubMed ID: 23610967
[TBL] [Abstract][Full Text] [Related]
18. 5-fluorouracil loaded guar gum microspheres for colon delivery: preparation, characterization and in vitro release.
Kaushik D; Sardana S; Mishra DN
Yao Xue Xue Bao; 2009 Nov; 44(11):1278-84. PubMed ID: 21351727
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity and antitumour activity of 5-fluorouracil-loaded polyhydroxybutyrate and cellulose acetate phthalate blend microspheres.
Chaturvedi K; Tripathi SK; Kulkarni AR; Aminabhavi TM
J Microencapsul; 2013; 30(4):356-68. PubMed ID: 23078151
[TBL] [Abstract][Full Text] [Related]
20. Stomach-specific drug delivery of 5-fluorouracil using ethylcellulose floating microspheres.
Vaghani S; Vasanti S; Chaturvedi K; Satish CS; Jivani NP
Pharm Dev Technol; 2010; 15(2):154-61. PubMed ID: 20214502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
